Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
48.92
+1.54 (3.25%)
At close: Dec 5, 2025, 4:00 PM EST
50.64
+1.72 (3.52%)
After-hours: Dec 5, 2025, 7:45 PM EST
Rigel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 888 | 296 | 253 | 259 | 453 | 591 | |
| Market Cap Growth | 110.82% | 17.18% | -2.48% | -42.79% | -23.38% | 64.89% | |
| Enterprise Value | 812 | 335 | 295 | 269 | 403 | 560 | |
| Last Close Price | 48.92 | 16.82 | 14.50 | 15.00 | 26.50 | 35.00 | |
| PE Ratio | 7.89 | 16.95 | - | - | - | - | |
| Forward PE | 12.56 | 17.39 | - | - | - | - | |
| PS Ratio | 3.10 | 1.65 | 2.18 | 2.24 | 3.27 | 5.45 | |
| PB Ratio | 7.55 | 90.11 | -8.83 | -19.04 | 14.92 | 17.38 | |
| P/TBV Ratio | 9.62 | - | - | - | 14.92 | 17.38 | |
| P/FCF Ratio | 13.03 | 9.43 | - | - | 86.30 | - | |
| P/OCF Ratio | 13.02 | 9.41 | - | - | 77.10 | - | |
| EV/Sales Ratio | 2.88 | 1.87 | 2.55 | 2.33 | 2.90 | 5.15 | |
| EV/EBITDA Ratio | 6.69 | 12.69 | - | - | - | - | |
| EV/EBIT Ratio | 6.82 | 13.86 | - | - | - | - | |
| EV/FCF Ratio | 11.91 | 10.67 | - | - | 76.67 | - | |
| Debt / Equity Ratio | 0.52 | 30.40 | -3.64 | -6.44 | 3.01 | 1.15 | |
| Debt / EBITDA Ratio | 0.50 | 3.68 | - | - | - | - | |
| Debt / FCF Ratio | 0.89 | 3.18 | - | - | 17.38 | - | |
| Asset Turnover | 1.48 | 1.27 | 0.92 | 0.77 | 1.00 | 0.84 | |
| Inventory Turnover | 3.31 | 5.49 | 2.76 | 5.17 | 10.82 | 12.21 | |
| Quick Ratio | 1.94 | 1.88 | 1.64 | 1.51 | 2.21 | 1.80 | |
| Current Ratio | 2.28 | 2.13 | 1.86 | 1.78 | 2.43 | 2.18 | |
| Return on Equity (ROE) | 220.06% | - | - | -699.04% | -55.63% | -67.72% | |
| Return on Assets (ROA) | 38.93% | 10.75% | -10.68% | -24.34% | -8.77% | -14.04% | |
| Return on Capital (ROIC) | 56.31% | 16.92% | -17.95% | -37.50% | -12.50% | -22.19% | |
| Return on Capital Employed (ROCE) | 80.30% | 24.00% | -33.60% | -85.00% | -18.80% | -41.70% | |
| Earnings Yield | 12.76% | 5.90% | -9.92% | -22.59% | -3.95% | -5.03% | |
| FCF Yield | 7.67% | 10.61% | -2.27% | -28.62% | 1.16% | -9.04% | |
| Buyback Yield / Dilution | -4.06% | -1.64% | -2.07% | 0.00% | -1.03% | -0.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.